|
|
|
|
|
|
|
|
|
|
open access
"...In a retrospective analysis including 33 NENs, the objective response rate was 25% with a three-drug regimen of streptozotocin/5-FU and cisplatin.82 Although this study is small and based on heterogeneous primary tumor sites (lung [n = 8], gastrointestinal [n = 9], ovarian [n = 1], unknown primary [n = 15])....
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.